Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.694
+0.018 (2.65%)
At close: Dec 20, 2024, 4:00 PM
0.708
+0.014 (1.97%)
After-hours: Dec 20, 2024, 4:46 PM EST
VRCA's stock price has decreased by -87.51% in the past year and price targets may not have had time to catch up.
Verrica Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Hold
Price Target
$6.00
Upside
+764.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 5, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | +188.10% | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +1,340.51% | Oct 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +1,484.56% | Oct 4, 2024 |
| Needham | Needham | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | +1,628.61% | Oct 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 2, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +1,772.66% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +1,628.61% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,204.81% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +1,916.71% | May 14, 2024 |
| Needham | Needham | Strong Buy Maintains $8 → $16 | Strong Buy | Maintains | $8 → $16 | +2,204.81% | May 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +1,052.41% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +1,772.66% | Mar 1, 2024 |
| Jefferies | Jefferies | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,340.51% | Dec 15, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.